Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
MEDvidi does not accept insurance for its consultations for follow-ups
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with progressive metastatic castration-resistant prostate cancer (mCRPC): Multi-centre phase I/II study [abstract]
Informed consumers are better equipped to: evaluate risks recognize misleading claims understand regulatory warnings avoid potentially harmful products Education does not encourage useit protects individuals from harm by promoting critical thinking and awareness
Pereira FWL et al
I originally ordered this starter kit a couple of weeks ago , i was slightly confused so I emailed customer service who got back to me almost immediately
US$ 25.81
US$ 26.17
US$ 21.16
US$ 23.76
US$ 22.58
US$ 27.33
US$ 22.07
US$ 27.22
US$ 26.76
